Found 0 matching trials
Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer PHASE2 Q3week carboplatin with weekly abraxane and trastuzumab as neoadjuvant ther...
Show More Learn More & Join Trial
Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer PHASE3 The purpose of this phase 3B trial was to see how well a new trial drug (de...
Show More Location
Alabama Research Center
Learn More & Join Trial
Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer PHASE2 The usual approach to care for hormone receptor positive, HER2 positive bre...
Show More Location
Legacy Mount Hood Medical Center
Learn More & Join Trial
Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant Endocrine or Chemotherapy N/A In estrogen receptor (ER)-positive breast cancer (BC), human epidermal grow...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial PHASE2 VALENTINE is a parallel, non-comparative, three-arm, randomized 1:2:2 open-...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer PHASE2 RATIONALE: Androgens can stimulate the growth of prostate cancer cells. Dru...
Show More Location
CCOP - Scottsdale Oncology Program
Learn More & Join Trial
Bone Metastasis and Surgery in Breast Cancer N/A A registry trial evaluating resection of the primary breast tumor in women ...
Show More Location
Istanbul University Medical faculty
Learn More & Join Trial
CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer PHASE1 This is a multi-center, open label, randomized study. Patients will be rand...
Show More Learn More & Join Trial
Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer PHASE3 This was an open-label, randomized controlled trial that aims to compare th...
Show More Location
Cancer Hospital/ Institute, Fudan University
Learn More & Join Trial
ABCSG 61 / TEODOR : Neoadjuvant TrEatment Optimization Driven by Circulating Tumor DNA and endOcrine Responsiveness NA The goal of this performance study is to learn if treatment with neoadjuvan...
Show More Location
Allg. Gynäkologie u. gyn. Onkologie/Senologie
Learn More & Join Trial